ADP-ribosylation factors (ARFs) are small GTP-binding proteins that are regulators of vesicle trafficking in eukaryotic cells [1] . ARNO is a member of the family of guanine nucleotide exchange factors for ARFs which includes cytohesin-1 and GRP-1 [2-5]. Members of this family contain a carboxy-terminal pleckstrin homology (PH) domain which, in the case of GRP-1, has been shown to bind the second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) in preference to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P 2 ) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P 2 ) in vitro [3,4]. Here, we show that recombinant ARNO has the binding characteristics of a PIP 3 receptor and that this activity is restricted to the PH domain. When expressed in murine 3T3 L1 adipocytes, ARNO tagged using green fluorescent protein (GFP) is localised exclusively in the cytoplasm. Stimulation with insulin, however, causes a rapid (< 50 second) PH-domain-dependent translocation of GFP-ARNO to the plasma membrane. This translocation is blocked by the PI(4,5)P 2 3-kinase (PI 3-kinase) inhibitors wortmannin and LY294002, and by co-expression with a dominant-negative p85 mutant, suggesting that the translocation is a consequence of insulin stimulation of PI 3-kinase. Our data strongly suggest that ARNO binds PIP 3 in vivo and that this interaction causes a translocation of ARNO to the plasma membrane where it might activate ARF6 and regulate subsequent plasma membrane cycling events. 
Increasing evidence has implicated the 3-phosphorylated inositol lipids, in particular PIP 3 , in the regulation of ARF signalling through their ability to interact with the ARF exchange factors GRP-1 [3, 4] , cytohesin-1 [5] and possibly ARNO. To test whether ARNO binds PIP 3 , we have isolated a full-length human ARNO cDNA that contains an open reading frame encoding a protein of 399 amino acids with a predicted molecular mass of 47 kDa (the protein sequence is identical to that of the previously cloned human ARNO [2] ). The full-length ARNO cDNA was cloned into the pGEX4T-3 expression vector to allow expression and purification of recombinant protein for binding analysis.
Our approach to identifying putative PIP 3 receptors stems from our previous work on the characterisation of receptors for the cytosolic second messenger inositol 1,3,4,5-tetrakisphosphate (IP 4 ) [6] . PIP 3 has IP 4 as its inositol headgroup, with the distinction that the 1-phosphate is not free, as in IP 4 , but is attached via glycerol to the fatty acids ( Figure 1a ). This has led us to predict that a PIP 3 receptor may in fact bind IP 4 in vitro [6] . It would be expected, however, that esterification of the 1-phosphate of IP 4 , particularly with glycerol or diacetylglycerol (to form GroPIns (3, 4, 5 )P 3 and diacetyl GroPIns (3, 4, 5 )P 3 , respectively), would result in a decrease in binding affinity to an IP 4 receptor, but would not affect, or might even increase, the binding affinity to a PIP 3 receptor. As shown in Figure 1b , IP 4 bound to ARNO with high affinity and specificity. The K d value for IP 4 (that is, the concentration required to compete for 50% of bound [ 32 P]IP 4 ) was 69.3 ± 4.1 nM (n = 3 from three separate purifications). The other inositol phosphates tested, namely Ins(1,3,4,5,6)P 5 , IP 6 , Ins(1,4,5)P 3 and Ins(1,3,4)P 3 , had K d values of 6,239 ± 352, > 10,000, > 10,000 and > 10,000 nM, respectively (n = 3 for each inositol phosphate). GroPIns (3, 4, 5 )P 3 and diacetyl GroPIns (3, 4, 5 These results suggest that ARNO does indeed constitute a putative PIP 3 receptor, in that it specifically recognises the 1,3,4,5-phosphate configuration on the inositol ring in preference to the 1,4,5 or 1,3,4 configuration of PI(4,5)P 2 and PI(3,4)P 2 , respectively. Moreover, unlike the IP 4 receptor GAP1 IP4BP [6] , it can accommodate a glycerol substitution on the 1-phosphate. In order to map this binding site, we have constructed fusion proteins comprising glutathione-S-transferase (GST) and either ARNO lacking the carboxy-terminal PH domain (GST-ARNO∆PH) or simply the PH domain of ARNO itself (GST-ARNOPH). Only proteins containing the PH domain bound IP 4 ( Figure 1c ), ARNOPH having a similar affinity and specificity to full-length ARNO (data not shown).
To overcome the limitations intrinsic to in vitro binding assays, we have used murine 3T3 L1 adipocytes to address whether ARNO does indeed interact with PIP 3 in vivo, as stimulation of these cells with insulin results in an activation of PI 3-kinase and hence an elevation in PIP 3 levels [7] . The subcellular localisation of ARNO was examined using a chimaera of GFP fused to the amino terminus of ARNO (GFP-ARNO). In unstimulated adipocytes, GFP-ARNO was expressed in the cytoplasm and was excluded from the nucleus and fat droplets ( Figure 2a ). Addition of insulin (200 nM) caused an almost complete translocation of GFP-ARNO to the plasma membrane ( Figure 2b ). This translocation required the PH domain of ARNO as, first, its deletion prevented translocation (data not shown) and, second, a fusion protein between GFP and just the PH domain of ARNO (amino acids 262-399; GFP-ARNOPH) translocated in response to insulin with a similar time course to that of full-length ARNO (Figure 2c,d ).
To address whether this translocation required the activation of PI 3-kinase, we preincubated transfected adipocytes with the chemically unrelated PI 3-kinase inhibitors wortmannin or LY294002 [8, 9] . In the absence of any inhibitor, insulin caused a translocation of GFP-ARNO in 94.2% of the cells (n = 33), whereas in the presence of 100 nM wortmannin, the insulin-dependent translocation of GFP-ARNO occurred in only 4.3% of cells (n = 23). Similarly, in the presence of 50 µM LY294002, insulin-induced translocation occurred in only 5.5% of cells (n = 36). Finally, insulin-induced translocation occurred in just 3.7% of cells (n = 34) when we co-expressed a dominant-negative p85 (∆p85), which blocks the elevation in Each data point is from three independent determinations. Scatchard analysis revealed a single class of binding site (data not shown).
[ 32 P]IP 4 competition binding assays were performed as described in [15] and the isolation of GST fusion proteins achieved as in [16] . 
Figure 2
Insulin-induced translocation of GFP-ARNO to the plasma membrane is dependent on a functional PH domain. Murine 3T3 L1 adipocytes were microinjected with plasmids containing either (a,b) GFP-ARNO or (c,d) GFP-ARNOPH. After 24 h, the cells were serum starved and then imaged by laser-scanning confocal microscopy in the absence of insulin (a,c). The cells were then incubated in the presence of 200 nM insulin, and imaged again after 1 min (b,d). The scale bar is 10 µm. The nuclear localisation of GFP-ARNOPH is due to its small size (approximately 37 kDa), which allows free access through the nuclear pore which is restricted for the larger 74 kDa GFP-ARNO.
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PIP 3 by uncoupling the ability of activated tyrosine-kinase receptors to stimulate PI 3-kinase [10] .
Using time-lapse confocal microscopy we have examined the kinetics of the translocation of full-length GFP-ARNO. An initial appearance of GFP-ARNO at the plasma membrane occurred within 30 seconds of insulin addition, and was complete within 50 seconds, at which time an almost total clearance of cytosolic GFP-ARNO had occurred (Figure 3a ). Of particular interest was the rapid appearance of GFP-ARNO in membrane ruffles. Time-lapse confocal imaging of cells previously treated with insulin demonstrated that addition of wortmannin (100 nM) promoted rapid displacement of GFP-ARNO from the plasma membrane back into the cytosol, a process that was completed within 60-70 seconds (Figure 3b ). The dynamics of these translocations can be seen by viewing the animated sequence available as Supplementary material (published with this paper on the internet).
In summary therefore, we have clearly demonstrated that the ability of insulin to stimulate PI 3-kinase is vital for the translocation of ARNO to the plasma membrane in 3T3 L1 adipocytes. This, along with the in vitro binding data and the rapid kinetics of insulin and wortmannin action on GFP-ARNO subcellular distribution, strongly suggest that ARNO is interacting with PIP 3 in vivo. Consequently, using time-lapse confocal microscopy, we can visualise the dynamics of PIP 3 production within the plasma membrane of single living cells. As ARNO has been shown to function as an exchange factor for the plasma-membrane-located ARF6 [11, 12] , we would propose that the ability of ARF6 to regulate membrane cycling events at the plasma membrane [13] might be under the control of PIP 3 .
Materials and methods

Cloning of human ARNO
Homologous primers (sense 5′-CGGAATTCCATGGAGGACGGCGT-TTATGAA-3′ {primer 1} and antisense 5′-CGCGTCGACTCAGGGCT-GCTCCTGCTTCTT-3′ {primer 2}) designed from the published human ARNO sequence [2] , were used to amplify by High Fidelity PCR (Boehringer), full-length ARNO from a human circulating-blood cDNA library (Strategene No. 938202). The product was digested with EcoRI and SalI and cloned into the corresponding sites of both the pGEX4T-3 (Pharmacia) and pEGFP-C1 (Clontech) vectors. All constructs were fully sequenced before use.
Cloning of pGEX-ARNO and pEGFP-ARNO deletion mutants
The deletion mutants were produced by PCR with primers designed to amplify the required fragment of cDNA (for ARNO∆PH, primers were sense primer 1 and antisense 5′-CGCGTCGACTCAGTCATTCCCGT-CATCCTCAGG-3′; for ARNOPH, sense 5′-CGGAATTCCATGCGG-GAGGGCTGGCTCCTGAAG-3′ and antisense primer 2). PCR products were digested with EcoRI and SalI before ligation into the corresponding sites within pGEX4T-3 and pEGFP-C1. All constructs were fully sequenced before use.
Microinjection and confocal microscopy of 3T3 L1 adipocytes
Murine 3T3 L1 adipocytes were differentiated on glass coverslips coated with poly-lysine and were microinjected with plasmid (200 µg/ml) as described previously [14] ; 24 h later, the adipocytes were serum starved for 5 h before fluorescence analysis at 37°C in Krebs-Ringer phosphate buffer (136 mM NaCl, 4.7 mM KCl, 1.25 mM MgSO 4 , 1.25 mM CaCl 2 , 5 mM sodium phosphate) containing 2 mM NaHCO 3 and 25 mM HEPES, pH 7.4. Confocal microscopy was performed with a Leica DM IRBE inverted confocal microscope controlled with TCS-NT4 software (Leica).
Supplementary material
A time-lapse movie sequence of the translocation of ARNO to and from the plasma membrane is published with this paper on the internet.
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